These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16961787

  • 1. A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache.
    Lampl C, Marecek S, May A, Bendtsen L.
    Cephalalgia; 2006 Oct; 26(10):1203-8. PubMed ID: 16961787
    [Abstract] [Full Text] [Related]

  • 2. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 3. An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache.
    Saper JR, Winner PK, Lake AE.
    Headache; 2001 Apr; 41(4):357-68. PubMed ID: 11318882
    [Abstract] [Full Text] [Related]

  • 4. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G, Delbrück A, Schulze L, Kademann B, Bornhoevd K, Schäfer S, Schäuble B, TOPMAT-MIG-4009 investigators.
    Headache; 2009 Apr; 49(10):1454-65. PubMed ID: 19804392
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 6. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label prospective study.
    Rizzato B, Leone G, Misaggi G, Zivi I, Diomedi M.
    Clin Neuropharmacol; 2011 Sep; 34(2):74-8. PubMed ID: 21412201
    [Abstract] [Full Text] [Related]

  • 8. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.
    Donofrio PD, Raskin P, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI, CAPSS-141 Study Group.
    Clin Ther; 2005 Sep; 27(9):1420-31. PubMed ID: 16291415
    [Abstract] [Full Text] [Related]

  • 9. [Prevention of tension type headache with topiramate].
    Aleksić-Shihabi A, Lojen G, Vuković V.
    Acta Med Croatica; 2008 May; 62(2):145-9. PubMed ID: 18710078
    [Abstract] [Full Text] [Related]

  • 10. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV, Jevoux CC.
    Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
    [Abstract] [Full Text] [Related]

  • 11. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 12. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM, Salem HA, Ajlouni SF, Al-Safi SA.
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of topiramate in the treatment of pediatric chronic daily headache.
    Borzy JC, Koch TK, Schimschock JR.
    Pediatr Neurol; 2005 Nov; 33(5):314-6. PubMed ID: 16243217
    [Abstract] [Full Text] [Related]

  • 14. Nefazodone for chronic daily headache prophylaxis: an open-label study.
    Saper JR, Lake AE, Tepper SJ.
    Headache; 2001 May; 41(5):465-74. PubMed ID: 11380644
    [Abstract] [Full Text] [Related]

  • 15. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 May; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 16. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
    Schreiner A, Stollhoff K, Ossig W, Unkelbach S, Lüer W, Bogdanow M, Schauble B, TOPMAT-EPY-403 investigators.
    Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
    Ashtari F, Shaygannejad V, Akbari M.
    Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epilepsy outcomes in elderly treated with topiramate.
    Stefan H, Hubbertz L, Peglau I, Berrouschot J, Kasper B, Schreiner A, Krimmer J, Schauble B, TOP-GER-13.
    Acta Neurol Scand; 2008 Sep; 118(3):164-74. PubMed ID: 18384458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.